Company Strategy, Scientific Rationale and Therapeutic Candidate. StromaCare is dedicated to the development of innovative oncology drugs, based on modulation of stromal components, for the treatment of solid tumors.
Member count: 1-10
Founded date: 2020
Investors 1
| Date | Name | Website |
| 21.03.2022 | Turenne Ca... | turennecap... |